Quan Joanne — SEC Form 4 filings
SEC reporting owner CIK 1670138. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-18 to 2026-03-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 22,989 shares, $1,783,733 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 7,287 shares @ $91.98 ($670,243) in Mirum Pharmaceuticals, Inc., filed 2026-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF MEDICAL OFFICER | 8 | — | 4 legs · 22,989 sh · $1,783,733 | 16 |
Form 4 filings — Quan Joanne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 13,334 · Sale (S): 7,287 @ $91.98 · Option exercise (M): 13,334 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 18,140 (derivative) @ $0 · Grant/award (A): 11,760 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 3,334 · Sale (S): 1,822 @ $93.33 · Option exercise (M): 3,334 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 12,500 · Sale (S): 6,911 @ $90.27 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 12,500 · Sale (S): 6,969 @ $45.86 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 118 @ $21.05 | EDGAR |
| 2024-01-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1670138 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →